Exosome/Extracellular Vesicles-Based Therapeutics in Alzheimer’s Disease: Neuroprotective Roles and Future Perspectives
Journal of Molecular Neuroscience · 12.10.2025 · 75 (4)
DOI: 10.1007/s12031-025-02432-6 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Molecular Neuroscience, online erschienen am 12.10.2025. Verfasst von Negar Ebadpour und 4 weiteren Autor:innen. Beteiligte Einrichtung: Immunology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran. Hauptthemen laut MEDLINE: Alzheimer Disease, Exosomes, Extracellular Vesicles. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 66 Literaturangaben.
Themen: Demenz
Abstract (Originalsprache)
Alzheimer's disease (AD), a progressive neurodegenerative disorder, is marked by memory loss, cognitive decline, and characteristic pathological features including β-amyloid (Aβ) plaques, tau tangles, and neuroinflammation. Despite extensive research, effective therapies remain elusive. Exosome/EVs-based therapeutics have emerged as a promising avenue for AD treatment. Neuron-derived exosomes/extracellular vesicles (EVs) (NDEs) and stem cell-derived exosomes/EVs exhibit neuroprotective effects by promoting Aβ degradation, modulating tau pathology, and reducing inflammation. Notably, NDEs carry insulin-degrading enzyme (IDE) and cellular prion proteins (PrPC), aiding Aβ clearance. However, exosomes also present challenges, such as the potential propagation of pathogenic tau and complement-mediated neurotoxicity. Neural and mesenchymal stem cell-derived exosomes further demonstrate therapeutic efficacy by altering amyloid precursor protein processing and activating PI3K/Akt/mTOR signaling to reduce AD pathology. Despite these advancements, clinical translation requires a deeper understanding of exosome/EVs biology, improved isolation techniques, and personalized strategies. Continued research may establish exosomes as a transformative approach in AD therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Immunology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
- Student Research Committee, Mashhad University of Medical Sciences, Mashhad, Iran.
- Department of Molecular Biology and Genetics, Canakkale Onsekiz Mart University, Canakkale, 17100, Turkey.
- Department of Pharmaceutical Sciences, Dr. Harisingh Gour Vishwavidyalaya (A Central University), Sagar, 470003, Madhya Pradesh, India. prashantdops@gmail.com.
- Center for Global Health Research, Saveetha Medical College and Hospitals, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, India. amir_Saheb2000@yahoo.com.
- Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Islamic Republic of Iran. amir_Saheb2000@yahoo.com.
Zitieren
APA
Ebadpour, N., Abavisani, M., Karav, S., Kesharwani, P., & Sahebkar, A. (2025). Exosome/Extracellular Vesicles-Based Therapeutics in Alzheimer’s Disease: Neuroprotective Roles and Future Perspectives. Journal of Molecular Neuroscience, 75(4). https://doi.org/10.1007/s12031-025-02432-6
Vancouver
Ebadpour N, Abavisani M, Karav S, Kesharwani P, Sahebkar A. Exosome/Extracellular Vesicles-Based Therapeutics in Alzheimer’s Disease: Neuroprotective Roles and Future Perspectives. Journal of Molecular Neuroscience. 2025;75(4). doi:10.1007/s12031-025-02432-6
BibTeX
@article{Ebadpour2025,
author = {Ebadpour, Negar and Abavisani, Mohammad and Karav, Sercan and Kesharwani, Prashant and Sahebkar, Amirhossein},
title = {Exosome/Extracellular Vesicles-Based Therapeutics in Alzheimer’s Disease: Neuroprotective Roles and Future Perspectives},
journal = {Journal of Molecular Neuroscience},
year = {2025},
volume = {75},
number = {4},
doi = {10.1007/s12031-025-02432-6}
}
EUVIMED